Amyloid burden and neural function in people at risk for Alzheimer's Disease.
Amyloid burden and neural function in people at risk for Alzheimer's Disease.
复制标题
DOI:
10.1016/j.neurobiolaging.2013.09.028
复制
发表时间:
2014-03
影响因子:
4.2
通讯作者:
Sager MA
中科院分区:
文献类型:
--
作者:
Johnson SC;Christian BT;Okonkwo OC;Oh JM;Harding S;Xu G;Hillmer AT;Wooten DW;Murali D;Barnhart TE;Hall LT;Racine AM;Klunk WE;Mathis CA;Bendlin BB;Gallagher CL;Carlsson CM;Rowley HA;Hermann BP;Dowling NM;Asthana S;Sager MA
To determine the relationship between amyloid burden and neural function in healthy adults at risk for Alzheimer's Disease (AD), we used multimodal imaging with [C-11]Pittsburgh compound B positron emission tomography, [F-18]fluorodeoxyglucose, positron emission tomography, and magnetic resonance imaging, together with cognitive measurement in 201 subjects (mean age, 60.1 years; range, 46–73 years) from the Wisconsin Registry for Alzheimer's Prevention. Using a qualitative rating, 18% of the samples were strongly positive Beta-amyloid (Ab+), 41% indeterminate (Aβi), and 41% negative (Aβ–). Aβ+ was associated with older age, female sex, and showed trends for maternal family history of AD and APOE4. Relative to the Aβ– group, Aβ+ and Aβi participants had increased glucose metabolism in the bilateral thalamus; Aβ+ participants also had increased metabolism in the bilateral superior temporal gyrus. Aβ+ participants exhibited increased gray matter in the lateral parietal lobe bilaterally relative to the Aβ– group, and no areas of significant atrophy. Cognitive performance and self report cognitive and affective symptoms did not differ between groups. Amyloid burden can be identified in adults at a mean age of 60 years and is accompanied by glucometabolic increases in specific areas, but not atrophy or cognitive loss. This asymptomatic stage may be an opportune window for intervention to prevent progression to symptomatic AD.
登录
查看更多内容
影响因子:
11.2
作者:
Landau, Susan M.;Mintun, Mark A.;Joshi, Abhinay D.;Koeppe, Robert A.;Petersen, Ronald C.;Aisen, Paul S.;Weiner, Michael W.;Jagust, William J.
通讯作者:
Jagust, William J.
影响因子:
9.9
作者:
Honea, R. A.;Swerdlow, R. H.;Burns, J. M.
通讯作者:
Burns, J. M.
影响因子:
14.5
作者:
Chetelat, Gael;Villemagne, Victor L.;Rowe, Christopher C.
通讯作者:
Rowe, Christopher C.
DOI:
10.1523/jneurosci.3669-09.2009
发表时间:
2009-11-25
期刊:
The Journal of neuroscience : the official journal of the Society for Neuroscience
影响因子:
--
作者:
Cohen AD;Price JC;Weissfeld LA;James J;Rosario BL;Bi W;Nebes RD;Saxton JA;Snitz BE;Aizenstein HA;Wolk DA;Dekosky ST;Mathis CA;Klunk WE
通讯作者:
Klunk WE
DOI:
10.1016/j.jalz.2011.03.004
发表时间:
2011-05
期刊:
Alzheimer's & dementia : the journal of the Alzheimer's Association
影响因子:
--
作者:
Jack CR Jr;Albert MS;Knopman DS;McKhann GM;Sperling RA;Carrillo MC;Thies B;Phelps CH
通讯作者:
Phelps CH